Trastuzumab (Herceptin) belongs to a group of drugs called monoclonal antibodies. It’s a targeted therapy (also called biological therapy).
Targeted therapies block the growth and spread of cancer. They target and interfere with processes in the cells that cause cancer to grow.
Trastuzumab is the generic (non-branded) name of the drug. Its current brand name is Herceptin.